Bela Denes
Chief Tech/Sci/R&D Officer bei LANTHEUS HOLDINGS, INC.
Aktive Positionen von Bela Denes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LANTHEUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 07.04.2021 | - |
| American College of Surgeons | Corporate Officer/Principal | - | - |
Karriereverlauf von Bela Denes
Ehemalige bekannte Positionen von Bela Denes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - | - |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Chief Tech/Sci/R&D Officer | 01.04.2012 | - |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
- Börse
- Insiders
- Bela Denes
- Erfahrung
